SARS-CoV-2 test positivity rate in Reno, Nevada: association with PM2.5 during the 2020 wildfire smoke events in the western United States

被引:23
|
作者
Kiser, Daniel [1 ]
Elhanan, Gai [1 ]
Metcalf, William J. [1 ]
Schnieder, Brendan [2 ]
Grzymski, Joseph J. [1 ,3 ]
机构
[1] Desert Res Inst, Ctr Genom Med, Reno, NV 89512 USA
[2] Washoe Cty Hlth Dist Air Qual Management Div, Reno, NV USA
[3] Renown Hlth, Reno, NV USA
关键词
AMBIENT AIR-POLLUTION; HEALTH IMPACTS; MORTALITY;
D O I
10.1038/s41370-021-00366-w
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
BACKGROUND: Air pollution has been linked to increased susceptibility to SARS-CoV-2. Thus, it has been suggested that wildfire smoke events may exacerbate the COVID-19 pandemic. OBJECTIVES: Our goal was to examine whether wildfire smoke from the 2020 wildfires in the western United States was associated with an increased rate of SARS-CoV-2 infections in Reno, Nevada. METHODS: We conducted a time-series analysis using generalized additive models to examine the relationship between the SARS-CoV-2 test positivity rate at a large regional hospital in Reno and ambient PM2.5 from 15 May to 20 Oct 2020. RESULTS: We found that a 10 mu g/m(3) increase in the 7-day average PM2.5 concentration was associated with a 6.3% relative increase in the SARS-CoV-2 test positivity rate, with a 95% confidence interval (CI) of 2.5 to 10.3%. This corresponded to an estimated 17.7% (CI: 14.4-20.1%) increase in the number of cases during the time period most affected by wildfire smoke, from 16 Aug to 10 Oct. SIGNIFICANCE: Wildfire smoke may have greatly increased the number of COVID-19 cases in Reno. Thus, our results substantiate the role of air pollution in exacerbating the pandemic and can help guide the development of public preparedness policies in areas affected by wildfire smoke, as wildfires are likely to coincide with the COVID-19 pandemic in 2021.
引用
收藏
页码:797 / 803
页数:7
相关论文
共 13 条
  • [11] Association of Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence and State-Issued Nonpharmaceutical Interventions: United States, 1 August 2020 to 30 March 2021
    Miller, Maureen J.
    Himschoot, Austin
    Fitch, Natalie
    Jawalkar, Sucheta
    Freeman, Dane
    Hilton, Charity
    Berney, Kevin
    Guy, Gery P., Jr.
    Benoit, Tina J.
    Clarke, Kristie E. N.
    Busch, Michael P.
    Opsomer, Jean D.
    Stramer, Susan L.
    Hall, Aron J.
    Gundlapalli, Adi, V
    MacNeil, Adam
    McCord, Russell
    Sunshine, Gregory
    Howard-Williams, Mara
    Dunphy, Christopher
    Jones, Jefferson M.
    CLINICAL INFECTIOUS DISEASES, 2022, 75 : S264 - S270
  • [12] Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022
    Iuliano, A. Danielle
    Brunkard, Joan M.
    Boehmer, Tegan K.
    Peterson, Elisha
    Adjei, Stacey
    Binder, Alison M.
    Cobb, Stacy
    Graff, Philip
    Hidalgo, Pauline
    Panaggio, Mark J.
    Rainey, Jeanette J.
    Rao, Preetika
    Soetebier, Karl
    Wacaster, Susan
    Ai, ChinEn
    Gupta, Vikas
    Molinari, Noelle-Angelique M.
    Ritchey, Matthew D.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (04): : 146 - 152
  • [13] SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason
    Mack, Christina D.
    DiFiori, John
    Tai, Caroline G.
    Shiue, Kristin Y.
    Grad, Yonatan H.
    Anderson, Deverick J.
    Ho, David D.
    Sims, Leroy
    LeMay, Christopher
    Mancell, Jimmie
    Maragakis, Lisa L.
    JAMA INTERNAL MEDICINE, 2021, 181 (07) : 960 - 966